SecBot SecBot
SECBOTREPLAY Home › Report › YARW

YARW · Spruce Street 6.4% passive stake

Yarrow Bioscience, Inc. · SC 13G filed Nov 13, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

SC 13G filed Nov 13, 2026 at 16:04 ET

Spruce Street Capital LP filed a Schedule 13G disclosing a 6.4% passive stake in Yarrow Bioscience, representing 607,382 shares as of September 30, 2026. This is a new filing by Spruce Street, adding to a series of recent 13G filings by other institutional investors (Bellevue Group at 10.6%, Invus Global at 7.2%) following Yarrow's September 2026 equity offering. The passive certification and hedge fund identity suggest a routine investment, not an activist precursor.

  • Spruce Street Capital LP disclosed a 6.4% passive stake in Yarrow Bioscience, representing 607,382 shares
  • Stake based on 9,437,693 shares outstanding as of September 14, 2026, after the company's public offering
  • Filing certifies passive intent under Rule 13d-1(b), with no intention to influence control
  • This is a new 13G filing, not an amendment to a prior filing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access